These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7950152)

  • 1. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.
    Wagner D; Kern WV; Kern P
    Clin Investig; 1994 Jun; 72(6):417-23. PubMed ID: 7950152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
    Coukell AJ; Spencer CM
    Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
    Amantea MA; Forrest A; Northfelt DW; Mamelok R
    Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
    Northfelt DW; Dezube BJ; Thommes JA; Levine R; Von Roenn JH; Dosik GM; Rios A; Krown SE; DuMond C; Mamelok RD
    J Clin Oncol; 1997 Feb; 15(2):653-9. PubMed ID: 9053490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
    Simpson JK; Miller RF; Spittle MF
    Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
    Harrison M; Tomlinson D; Stewart S
    J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.
    James ND; Coker RJ; Tomlinson D; Harris JR; Gompels M; Pinching AJ; Stewart JS
    Clin Oncol (R Coll Radiol); 1994; 6(5):294-6. PubMed ID: 7530036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma.
    Bogner JR; Kronawitter U; Rolinski B; Truebenbach K; Goebel FD
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):463-8. PubMed ID: 8158540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW; Dezube BJ; Thommes JA; Miller BJ; Fischl MA; Friedman-Kien A; Kaplan LD; Du Mond C; Mamelok RD; Henry DH
    J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.
    Northfelt DW; Martin FJ; Working P; Volberding PA; Russell J; Newman M; Amantea MA; Kaplan LD
    J Clin Pharmacol; 1996 Jan; 36(1):55-63. PubMed ID: 8932544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
    Fischl MA; Krown SE; O'Boyle KP; Mitsuyasu R; Miles S; Wernz JC; Volberding PA; Kahn J; Groopman JE; Feinberg J
    J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):259-64. PubMed ID: 8450401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
    Goebel FD; Goldstein D; Goos M; Jablonowski H; Stewart JS
    Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
    Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ
    J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
    Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
    Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M
    Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Miles SA; Mitsuyasu RT; Montgomery T; McCarthy S; Espina BM; Feldstein M; Levine AM
    AIDS; 1994 Dec; 8(12):1695-9. PubMed ID: 7534090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
    Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
    Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
    Hengge UR; Brockmeyer NH; Baumann M; Reimann G; Goos M
    Lancet; 1993 Aug; 342(8869):497. PubMed ID: 8102452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.